Home Multimedia Webinars


In Silico Antibody Design: Navigating Latest Trends and Envisioning Future Technologies

In this GEN webinar, Dr. Anne Goupil-Lamy from BIOVIA will discuss how machine learning and AI is accelerating the discovery of novel biotherapeutics, including antibodies.

Unlocking the Potential of Electroporation for Studying Ion Channel-Related Disorders and iPSCs

In this GEN webinar, Dr. Alfred George from Northwestern University Feinberg School of Medicine will discuss an electroporation approach that addresses efficiency challenges and engineers target cells at unprecedented scale.

From Flat to Functional: Tools and Techniques for Working with Spheroids and Organoids

In this GEN webinar, Corning Life Sciences’ Hilary Sherman will discuss the advantages of spheroid and organoid models over traditional 2D models and highlight why they are best option for biomedical research and drug development.

Effective Engineering of Bispecific/Multispecific Antibodies for Biotherapeutics Development

In this GEN webinar, Dr. Jianqing Xu, Head of the Protein Design and Engineering Excellence Center at WuXi Biologics, will discuss tools and strategies for effectively addressing the technical challenges of engineering bispecific and multispecific antibodies.

Microbial Expression Systems Get a Much Needed Upgrade

In TODAY’s GEN webinar, Dr. Nordwald from KBI Biopharma will discuss how the groundbreaking PUREplatform improves microbial therapeutic protein expression. You’ll learn how PUREplatform can transform microbial drug substance production at a fraction of the scales previously needed.

Solutions for In-Process Monitoring of Critical Quality Attributes in Bioprocessing

Improving process understanding allows process engineers to develop manufacturing processes that reduce the potential for batch failure or manufacturing delay. this GEN talk, sponsored by Waters, describes the automation of routine product quality and cell culture media analysis to eliminate human errors with automated sample preparation and data transfer.

CRISPR Cures 2033: Expanding the Public Health Impact of Gene Editing

In this live webinar, sponsored by Aldevron, one of the pioneers of human genome editing—Dr. Fyodor Urnov—will lay out the urgent challenge facing the clinical genome editing community in terms of expanding the public health impact of CRISPR-Cas.

An Automated Imaging Strategy for Characterizing Particles in Biotherapeutic Stability Studies

In this webinar, sponsored by Halo Labs, you’ll learn how Aura+ leverages innovative modern imaging and fluorescence microscopy techniques developed specifically for the life sciences to characterize protein, gene, and cell therapy products in stability studies.

Accelerating mRNA-LNP Medicine Development from Concept to Clinic

In this GEN webinar, three experts will discuss how Precision Nanosystems’ modular microfluidic platform technologies and analytics can help scientists successfully design, develop, test, and scale-up promising mRNA-LNP vaccines and therapeutics from concept to clinic.

Strategies for Multi-Omic Analysis of Ovarian Tumor Tissue Using Imaging Mass Cytometry™

In thi’s GEN webinar, sponsored by Standard BioTools, Dr. Sammy Ferri-Borgogno, from MD Anderson Cancer Center, will discuss how a multi-omic approach to tissue imaging can reliably characterize the tumor microenvironment in ovarian cancer.

Beyond AAV: Novel Strategies for Genetic Payload and Delivery Systems

In TODAY’s cell and gene therapy webinar, sponsored by Revvity, our distinguished speakers, Dr. Dominik Fischer and Dr. Michelle Fraser, will discuss recent advances and novel strategies for genetic modulation and payload delivery systems.

Host Cell Protein (HCP) Profiling and Quantitation in Gene Therapy Products with the Orbitrap Astral Mass Spectrometer

In this webinar, sponsored by Thermo Fisher Scientific, our special guest Jonathan Bones from NIBRT, will demonstrate approaches to over come key challenges with AAV HCP analysis, such as the highly complex proteome background and large dynamic range which necessitate the need for high sensitivity enabling the detection and quantification of low abundant HCPs, essential for safe and efficacious production of these advanced biotherapeutics.

doggybone DNA: A Rapid Enzymatic GMP Starting Material for mRNA Production

In this GEN webinar, presenters Benyamin Panah, PhD, RNA subject matter expert, Touchlight, and Scott Alderucci, director of process development, Curia, will address the evolving challenges of pDNA in mRNA manufacture, and discuss an alternative to pDNA—an enzymatic, antibiotic-free DNA vector called doggybone DNA (dbDNA™).